Journal

Introduction — The Gut Microbiota as a Biological Interface of Ageing

Biological ageing cannot be reduced to the passive accumulation of molecular damage. It reflects a gradual loss of functional coherence across biological systems, characterised by chronic low-grade inflammation, declining metabolic resilience, impaired mitochondrial function and dysregulated immunity. Within this framework, contemporary research increasingly converges on a reality that is now difficult to overlook: a substantial part of this biological drift originates in the gut, at the interface between the organism and its environment [1–3].

The gut microbiota is not a mere digestive aid. It is a metabolically active ecosystem capable of transforming dietary substrates into biological signals, shaping immune education, supporting intestinal barrier integrity and modulating the intensity of systemic inflammation [3–6]. As a result, qualitative and functional changes within this ecosystem occupy a central position in our understanding of biological ageing.

Within a Cellular Nutrition framework, this dimension becomes structurally decisive. If nutrition acts as a set of signals interpreted by the cell, then everything that conditions the transformation, immune tolerance and transmission of these signals — foremost among them the microbiota and the intestinal barrier — directly influences the biological trajectory of ageing.

I — Ageing of the Microbiota: Heterogeneity, Fragility and Loss of Protective Functions

Contrary to a simplified view, microbiota ageing does not follow a universal linear pattern. Longitudinal and cross-sectional studies consistently show a marked increase in interindividual variability with age, reflecting heightened sensitivity to environmental, dietary, medical and social factors [7]. In older adults, the microbiota thus becomes a particularly faithful mirror of the overall biological terrain.

A landmark study published in Nature demonstrated that, in elderly populations, microbiota composition strongly correlated with living environment and degree of functional independence, suggesting that dietary diversity and general health status profoundly shape the intestinal ecosystem [7]. The most fragile profiles were characterised by reduced microbial diversity and impaired key functions, notably those involved in beneficial metabolite production and maintenance of the intestinal barrier.

Recent reviews dedicated to microbiota and ageing confirm this overarching pattern: individuals with increased frailty exhibit a decline in protective microbial functions, a relative expansion of opportunistic microorganisms and greater ecological instability [1,8]. These changes should not be interpreted as simple markers of chronological age, but rather as expressions of distinct biological trajectories, more or less favourable.

Importantly, these evolutions are neither inevitable nor uniform. Some older adults retain a diverse and functionally robust microbiota, reinforcing the distinction between chronological ageing and biological ageing.

II — Intestinal Barrier, Permeability and Systemic Low-Grade Inflammation

The intestinal barrier is a dynamic, multifactorial system integrating mucus, epithelium, tight junctions, microbiota and local immunity. Its dual role is to enable selective nutrient absorption while maintaining controlled immune tolerance to microbial signals, and to prevent excessive translocation of pro-inflammatory components [3,9].

With advancing age and in contexts of dysbiosis, this barrier may become compromised. Contemporary scientific literature shows that increased intestinal permeability facilitates the translocation of bacterial components — notably lipopolysaccharides — capable of chronically activating innate immunity and sustaining systemic low-grade inflammation [3,9]. This state, often referred to as metabolic endotoxaemia, does not correspond to acute infection but to a silent, repeated immune stimulation.

Recent longitudinal studies have identified associations between indirect markers of intestinal permeability and endotoxaemia, cardiometabolic risk and mortality in older populations [10]. These findings suggest that intestinal barrier status constitutes a measurable determinant of inflammatory burden and biological prognosis.

Methodological rigour remains essential. Specialist reviews emphasise the complexity of assessing intestinal permeability and the limitations of reductionist approaches based on single biomarkers [11]. The relevant scientific question is not to diagnose “leaky gut” in binary terms, but to evaluate the functional impact of the intestinal barrier on systemic inflammatory load.

III — Microbiota and Immunity: Continuous Modulation of the Inflammatory Terrain

The gut microbiota plays a central role in immune maturation and regulation. It influences immune cell differentiation, immunoglobulin A production, the balance between tolerance and inflammatory response, and the organism’s capacity to restrain excessive immune activation [4–6].

When the intestinal ecosystem is stable and functional, this interaction is predominantly mutualistic. Conversely, dysbiosis combined with barrier impairment promotes chronic immune activation, contributing to the establishment of a diffuse inflammatory state [3,12]. This mechanism directly links the microbiota to inflammaging, a defining feature of biological ageing.

Thus, part of the chronic inflammation observed with age does not arise solely from tissue senescence, but from sustained immune stimulation at biological interfaces — foremost among them the gut. This perspective profoundly reshapes prevention strategies: the objective is not to suppress inflammation, but to reduce the biological signals that maintain its chronic, unresolved nature.

IV — Microbiota, Metabolites and Mitochondrial Function

Mitochondrial function occupies a central place in the biology of ageing. Beyond energy production, mitochondria regulate innate immunity, oxidative stress and adaptive responses. The metabolic environment in which they operate directly influences their efficiency.

The microbiota contributes to this environment through the production of metabolites derived from dietary substrate fermentation. Short-chain fatty acids, particularly butyrate, exemplify this role. These molecules support intestinal barrier integrity, modulate gene expression through epigenetic mechanisms and exert well-documented immunomodulatory effects [13]. Their influence extends far beyond the gut, participating in systemic regulation of the inflammatory terrain.

Recent reviews examining microbiota–mitochondria interactions describe a complex, bidirectional dialogue. Microbial metabolites, inflammatory status and intestinal permeability affect mitochondrial function, while the host’s energetic and immune state feeds back into the intestinal ecosystem [14,15]. This interplay helps explain how chronic dysbiosis may, over time, contribute to declining cellular energy efficiency and reduced biological resilience.

V — Microbiota and Longevity: Lessons from Centenarians

Studies of exceptionally long-lived populations provide valuable insights. They show that healthy longevity is not necessarily associated with a simple increase in microbial diversity, but rather with distinct functional signatures.

A study published in Nature identified, in centenarians, an enrichment of microorganisms capable of producing specific secondary bile acids, associated with enhanced resistance to certain pathogens and more robust intestinal homeostasis [16]. These findings were complemented by research describing the immunometabolic role of bile acid derivatives, which modulate inflammation and immune responses through specific signalling pathways [17,18].

Together, these data suggest that longevity is better understood through the lens of adapted microbial functions than through taxonomic composition alone.

VI — Towards the Concept of Microbial Age and Cardiometabolic Risk

More recent research has sought to quantify a “microbial age” based on microbiota signatures. A 2024 study published in Nature Medicine proposed an indicator of microbial ageing associated with cardiovascular risk, suggesting that a microbiota with more favourable functional characteristics may modulate risk even in unfavourable metabolic contexts [19].

While these findings require cautious interpretation, they reinforce a central idea: the microbiota serves both as an integrated marker of biological terrain and as a potential lever for modifying risk trajectories.

European interventional data, notably from the NU-AGE project, further show that sustained dietary intervention can alter microbiota functions and be associated with reduced frailty and improved health parameters in older adults [20].

VII — Microbiota and the Effectiveness of Nutritional Strategies

Any nutritional strategy presupposes certain biological prerequisites: effective digestion and absorption, a functional intestinal barrier, and an immunometabolic context compatible with coherent cellular interpretation of nutritional signals.

The microbiota intervenes at each of these levels. It transforms dietary substrates into active metabolites, influences intestinal permeability, modulates systemic inflammation and shapes the metabolic environment governing energy regulation pathways and mitochondrial function [3–6,14,15]. When the intestinal ecosystem is compromised, nutrition becomes biologically less predictable, more inflammatory and less efficient.

This reality explains why a Cellular Nutrition approach cannot be reduced to the mere addition of nutrients. It requires consideration of the digestive and immune terrain as a prerequisite for optimal utilisation of nutritional signals.

VIII — Cellular Nutrition and the Microbiota: A Systemic Terrain-Based Approach

The objective is not to “normalise” the microbiota in a simplistic manner, but to restore key biological functions: intestinal barrier integrity, limitation of metabolic endotoxaemia, production of metabolites compatible with regulated immunity, and support of a coherent energetic environment.

Within this framework, Cellular Nutrition aligns with a logic of functional prevention. It aims to reduce the biological signals that sustain chronic inflammation and metabolic drift, while supporting adaptive mechanisms and biological resilience.

Conclusion — The Microbiota as a Modifiable Determinant of Biological Age

The microbiota does not, on its own, explain ageing. However, it connects several of its central mechanisms: low-grade inflammation, immunity, metabolism, mitochondrial function and interface integrity. As such, it constitutes a major determinant of the biological terrain.

Preserving healthier ageing requires maintaining coherence across biological systems. The gut, as a primary interface with the environment, plays a decisive role in this coherence. This is why the microbiota should be regarded not as a peripheral topic, but as a rigorous and credible lever in modern prevention of biological ageing.

Glossary

Gut microbiota
The community of microorganisms residing in the intestine and their metabolic functions.

Dysbiosis
Qualitative or functional alteration of the microbiota associated with an unfavourable inflammatory or metabolic terrain.

Intestinal barrier
A multifactorial protective system ensuring controlled separation between intestinal contents and the organism.

Intestinal permeability
A dynamic property of the intestinal barrier influencing the passage of molecules and microbial signals.

Metabolic endotoxaemia
Chronic presence of pro-inflammatory bacterial components in the bloodstream.

Short-chain fatty acids
Microbial metabolites (butyrate, propionate, acetate) involved in immunomodulation and barrier integrity.

Inflammaging
Chronic low-grade inflammation associated with biological ageing.

Immunosenescence
Progressive alteration of immune function with age.

Polypharmacy
Concurrent use of multiple medications, common in older adults.

Cellular Nutrition
A nutritional approach aimed at optimising the cellular environment and coherence of biological signals.

FAQ

Does the microbiota genuinely influence ageing?
Yes. It modulates inflammation, immunity, metabolism and mitochondrial function — all central determinants of biological ageing.

Is microbiota ageing inevitable?
No. It is strongly influenced by biological terrain, diet, medication and lifestyle.

What links the microbiota to inflammaging?
Dysbiosis and barrier impairment promote chronic low-grade inflammation.

Can medications accelerate ageing via the microbiota?
Certain drug classes may weaken the intestinal ecosystem and barrier, indirectly sustaining chronic inflammation.

Why does the microbiota condition nutritional effectiveness?
Because it transforms nutrients into active metabolites and shapes their biological interpretation.

Does Cellular Nutrition act on the microbiota?
Yes, by improving biological terrain, metabolic coherence and immune tolerance.

Bibliography

[1] Gyriki D. et al. (2025).
The gut microbiota and ageing: interactions, implications and interventions.
PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC12116569/

[2] Furman D. et al. (2019).
Chronic inflammation in the aetiology of disease across the life span.
Nature Medicine
https://www.nature.com/articles/s41591-019-0675-0

[3] Di Vincenzo F. et al. (2023).
Gut microbiota, intestinal permeability and systemic inflammation.
PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC10954893/

[4] Belkaid Y., Hand T.W. (2014).
Role of the microbiota in immunity and inflammation.
Cell
https://www.cell.com/cell/fulltext/S0092-8674(14)00240-0

[5] Tilg H., Moschen A.R. (2014).
Microbiota and inflammation.
Nature Reviews Immunology
https://www.nature.com/articles/nri3703

[6] Hotamisligil G.S. (2017).
Foundations of immunometabolism.
Immunity
https://www.cell.com/immunity/fulltext/S1074-7613(17)30359-8

[7] Claesson M.J. et al. (2012).
Gut microbiota composition correlates with diet and health in the elderly.
Nature
https://www.nature.com/articles/nature11319

[8] Tseng C.H. et al. (2025).
From dysbiosis to longevity: a narrative review of the gut microbiome and ageing.
PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC12515389/

[9] Nathan C., Ding A. (2010).
Non-resolving inflammation.
Cell
https://www.cell.com/cell/fulltext/S0092-8674(10)00128-7

[10] Parantainen J. et al. (2025).
Intestinal permeability, metabolic endotoxaemia and cardiometabolic risk.
ScienceDirect
https://www.sciencedirect.com/science/article/pii/S0021915025001182

[11] Alimentary Pharmacology & Therapeutics (2025).
Human intestinal barrier: optimal measurement and clinical relevance.
Wiley
https://onlinelibrary.wiley.com/doi/10.1111/apt.70225

[12] Franceschi C., Campisi J. (2014).
Chronic inflammation (inflammaging) and age-associated diseases.
Journal of Gerontology Series A
https://academic.oup.com/biomedgerontology/article/69/Suppl_1/S4/552493

[13] Kalkan A.E. et al. (2025).
Beyond the gut: butyrate’s systemic biological effects.
PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC12029953/

[14] Zachos K.A. et al. (2024).
Mitochondria–microbiota interactions in ageing.
PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC11306032/

[15] Kulkarni H. et al. (2025).
Mitochondria–gut microbiota crosstalk in ageing and disease.
ScienceDirect
https://www.sciencedirect.com/science/article/abs/pii/S0014299925003164

[16] Sato Y. et al. (2021).
Bile acid biosynthesis pathways enriched in centenarian microbiomes.
Nature
https://www.nature.com/articles/s41586-021-03832-5

[17] Cai J. et al. (2022).
Gut microbiota-derived bile acids in immunity and inflammation.
Cell Host & Microbe
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(22)00090-7

[18] Hofer U. (2021).
Unique bile acid metabolism in centenarians.
Nature Reviews Microbiology
https://www.nature.com/articles/s41579-021-00623-7

[19] Nature Medicine (2024).
Gut microbial age modulates cardiovascular disease risk.
https://www.nature.com/articles/s41591-024-03058-8

[20] Ghosh T.S. et al. (2020).
Mediterranean diet intervention alters the gut microbiome in older adults.
Gut
https://gut.bmj.com/content/69/7/1218

[21] Lange K. et al. (2016).
Effects of antibiotics on the gut microbiota.
Gut Microbes
https://www.tandfonline.com/doi/full/10.1080/19490976.2016.1241934

[22] Imhann F. et al. (2016).
Proton pump inhibitors and the gut microbiome.
Gut
https://gut.bmj.com/content/65/5/740

[23] Wu H. et al. (2017).
Metformin alters the gut microbiome.
Nature Medicine
https://www.nature.com/articles/nm.4345

[24] Rogers M.A.M., Aronoff D.M. (2016).
NSAIDs and the gut microbiome.
Gut
https://gut.bmj.com/content/65/9/1440

[25] The Lancet Gastroenterology & Hepatology (2023).
Drugs, the gut microbiome and health.
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00187-4/fulltext

[26] Gut (2024).
Medication-induced microbiota alterations in ageing populations.
https://gut.bmj.com/content/73/1/1